Year: 2020
Type: review
Abstract: Macrophages sustain tumour progression by facilitating angiogenesis, promoting immunosuppression, and enhancing cancer cell invasion and metastasis. They also modulate tumour response to anti-cancer therapy in pre-clinical models. This knowledge has motivated the development of agents that target tumour-associated macrophages (TAMs), some of which have been investigated in early clinical trials. Here, we provide a comprehensive overview of the biology and therapeutic targeting of TAMs, highlighting opportunities, setbacks, and new challenges that have emerged after a decade of intense translational and clinical research into these multifaceted immune cells. © 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Source: The Journal of Pathology
DOI: 10.1002/path.5403
Authors: Tim Beltraminelli, Michele De Palma
Institution: École Polytechnique Fédérale de Lausanne
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Awards: Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy, G4152814798, New insight into macrophage-regulated tumor angiogenesis: role of extracellular vesicles, G544591541, DICER control of tumor-associated macrophages, Role of extracellular vesicles in chemotherapy-induced metastasis
OpenAlex ID: W3007902371
